Blog

8-Year-Old Has Disease So Rare It Doesn’t Have a Name.  Now, he is the First in the World to Receive Treatment.  Amber Freed’s son Maxwell made history in September 2025 when he received treatment for “SLC6A1” thanks to her tireless work and a team of dedicated scientists.

A parent’s determination leads to rare disease treatment for her son: Maxwell Freed, an 8-year-old with the extremely rare neurodevelopmental disorder known as “SLC6A1”, has become the first person in the world to receive a treatment for it, thanks to his mother, Amber Freed, who spent years fundraising and pushing Scientists and Regulators to move the research forward. While a repurposed FDA-approved drug helped buy time early on, her advocacy helped drive the creation and testing of a new gene therapy that received FDA approval in June 2025. Maxwell received the one-time treatment in September 2025 and is now in rehabilitation and showing signs of progress.

FDA’s QMSR (Quality Management System Regulation) is Live:  Expert says new rule may be challenging for smaller firms, combination product makers

Medical device makers must comply with the U.S. Food and Drug Administration’s (FDA) Quality Management System Regulation (QMSR) after the rule took effect on Monday, 02 FEB 2026. Additionally, FDA inspections of device facilities will no longer be conducted under the prior Quality System Inspection Technique (QSIT) and instead will be carried out in accordance with a new Compliance Program Manual.

United States Completes WHO (World Health Organization) Withdrawal

The U.S. Department of Health and Human Services (DHHS) and the U.S. Department of State announced the United States’ completion of its withdrawal from the World Health Organization (WHO) due to the organization’s mishandling of the COVID-19 pandemic that arose out of Wuhan, China, its failure to adopt urgently needed reforms, and its inability to demonstrate independence from the inappropriate political influence of WHO member states.

FDA Takes Steps to Improve Gluten Ingredient Disclosure in Foods

On 21 JAN 2026 , the U.S. Food and Drug Administration issued a Request for Information (RFI) regarding labeling and preventing cross-contact of gluten in packaged food. The FDA is taking this action as a first step to improve transparency in disclosures of ingredients that impact certain health conditions, such as gluten for those with celiac disease, and other established food allergens.

Research breakthrough could help regrow lost limbs:  A team from Texas A&M University has uncovered a key to joint regeneration.

Researchers take a step toward limb regeneration: In a significant step toward full-limb regeneration, researchers at Texas A&M University have identified a fibroblast growth factor as a key protein that can regenerate an entire finger joint, including soft tissue. “Our expectation is that if we can figure out all the factors that regenerate a finger, then we could apply those factors anywhere on the rest of the arm, or even a leg, and regrow a limb,” said Assistant Professor Lindsay Dawson.